Abstract
Myasthenia Gravis: Challenges and Therapeutics Solution
Myasthenia gravis (MG) is an autoimmune disease leading to fluctuating muscle weakness and fatigability and patients have autoantibodies against the acetylcholine receptor. MG is a postsynaptic dis¬order caused by the antibody-mediated destruction of acetyl-choline receptors (AChRs) and blockage of the binding of acetylcholine to acetylcholine receptor. Lambert-Eaton myasthenic syndrome (LEMS) is distinct autoimmune disorders that affect neuromuscular transmission. A study by Jee-Ae Kim et al. showing same clinical features and electrophysiological finding in patients of MG and LEMS
Author(s):
Sandeep Kumar Singh, Vijay Kumar and Ashok Kumar
Abstract | Full-Text | PDF
Share this
30+ Million Readerbase
Abstracted/Indexed in
- Google Scholar
- Open J Gate
- Genamics JournalSeek
- The Global Impact Factor (GIF)
- China National Knowledge Infrastructure (CNKI)
- Directory of Research Journal Indexing (DRJI)
- WorldCat
- Proquest Summons
- Scientific Journal Impact Factor
- Secret Search Engine Labs
- Euro Pub
Open Access Journals
- Aquaculture & Veterinary Science
- Chemistry & Chemical Sciences
- Clinical Sciences
- Engineering
- General Science
- Genetics & Molecular Biology
- Health Care & Nursing
- Immunology & Microbiology
- Materials Science
- Mathematics & Physics
- Medical Sciences
- Neurology & Psychiatry
- Oncology & Cancer Science
- Pharmaceutical Sciences